[HTML][HTML] Sex differences in stress-related alcohol use
MKR Peltier, TL Verplaetse, YS Mineur, IL Petrakis… - Neurobiology of …, 2019 - Elsevier
Rates of alcohol use disorder (AUD) have increased in women by 84% over the past ten
years relative to a 35% increase in men. This substantive increase in female drinking is …
years relative to a 35% increase in men. This substantive increase in female drinking is …
Sex differences in neural mechanisms mediating reward and addiction
JB Becker, E Chartoff - Neuropsychopharmacology, 2019 - nature.com
There is increasing evidence in humans and laboratory animals for biologically based sex
differences in every phase of drug addiction: acute reinforcing effects, transition from …
differences in every phase of drug addiction: acute reinforcing effects, transition from …
Sex differences in dopamine release regulation in the striatum
The mesolimbic dopamine system—which originates in the ventral tegmental area and
projects to the striatum—has been shown to be involved in the expression of sex-specific …
projects to the striatum—has been shown to be involved in the expression of sex-specific …
Sex differences in the neurobiology of drug addiction
SAM Bobzean, AK DeNobrega, LI Perrotti - Experimental neurology, 2014 - Elsevier
Epidemiological data demonstrate that while women report lower rates of drug use than
men, the number of current drug users and abusers who are women continues to increase …
men, the number of current drug users and abusers who are women continues to increase …
[HTML][HTML] The kappa opioid receptor: from addiction to depression, and back
L Lalanne, G Ayranci, BL Kieffer, PE Lutz - Frontiers in psychiatry, 2014 - frontiersin.org
Comorbidity is a major issue in psychiatry that notably associates with more severe
symptoms, longer illness duration, and higher service utilization. Therefore, identifying key …
symptoms, longer illness duration, and higher service utilization. Therefore, identifying key …
Intracranial self-stimulation to evaluate abuse potential of drugs
SS Negus, LL Miller - Pharmacological reviews, 2014 - ASPET
Intracranial self-stimulation (ICSS) is a behavioral procedure in which operant responding is
maintained by pulses of electrical brain stimulation. In research to study abuse-related drug …
maintained by pulses of electrical brain stimulation. In research to study abuse-related drug …
Kappa opioid receptors drive a tonic aversive component of chronic pain
SS Liu, S Pickens, NE Burma… - Journal of …, 2019 - Soc Neuroscience
Pain is a multidimensional experience and negative affect, or how much the pain is
“bothersome”, significantly impacts the sufferers' quality of life. It is well established that the κ …
“bothersome”, significantly impacts the sufferers' quality of life. It is well established that the κ …
[HTML][HTML] Sex differences in kappa opioid receptor function and their potential impact on addiction
EH Chartoff, M Mavrikaki - Frontiers in neuroscience, 2015 - frontiersin.org
Behavioral, biological, and social sequelae that lead to drug addiction differ between men
and women. Our efforts to understand addiction on a mechanistic level must include studies …
and women. Our efforts to understand addiction on a mechanistic level must include studies …
Dynorphin/kappa opioid receptor signaling in preclinical models of alcohol, drug, and food addiction
A Karkhanis, KM Holleran, SR Jones - International review of neurobiology, 2017 - Elsevier
The dynorphin/kappa opioid receptor (KOR) system is implicated in the “dark side” of
addiction, in which stress exacerbates maladaptive responses to drug and alcohol …
addiction, in which stress exacerbates maladaptive responses to drug and alcohol …
Targeting opioid dysregulation in depression for the development of novel therapeutics
CA Browne, I Lucki - Pharmacology & therapeutics, 2019 - Elsevier
Since the serendipitous discovery of the first class of modern antidepressants in the 1950's,
all pharmacotherapies approved by the Food and Drug Administration for major depressive …
all pharmacotherapies approved by the Food and Drug Administration for major depressive …